Filing Details

Accession Number:
0001477932-15-006851
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-10 19:21:05
Reporting Period:
2015-09-08
Filing Date:
2015-11-10
Accepted Time:
2015-11-10 19:21:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1029125 Sun Biopharma Inc. SNBP Pharmaceutical Preparations (2834) 870543922
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1642684 John Robert Sargent 1951 Logan Ave
Salt Lake City UT 84108
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-09-08 216,705 $0.00 74,825 No 4 S Indirect By Rare Principle, L.C.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Rare Principle, L.C.
Footnotes
  1. Mr. Sargent (through his entity) sold $125,000 of the issuer's debt and 216,705 shares of the issuer's common stock for $125,000 pursuant to transactions reported in the issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission ("SEC") on August 13, 2015, Current Report on Form 8-K filed with the SEC on September 11, 2015, and Schedule 14C filed with the SEC on August 7, 2015, among others.